Related Experiment Video
Updated: Apr 25, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
[Sarcoïdose in patient with chronic hepatitis C treated with pegylated interferon]
M K Moudden1, T Ziadi2, A Al Bouzidi3
1Service de médecine interne, hôpital militaire Moulay-Ismail, BP S15, Meknès, Maroc.
Abstract:
Induced sarcoïdosis during therapy with interferon for chronic viral hepatitis C involves mainly by isolated cutaneous lesions or with lung lesions. Systemic forms are very rare. We report an observation. A 50-year-old patient developed a systemic sarcoïdosis two months after the end of treatment for hepatitis C with pegylated interferon and ribavirin with lung, joint and hepatic manifestations. After starting corticosteroid therapy, the evolution was favourable. Induced sarcoïdosis by interferon therapy is rare, treatment necessitates stopping interferon, and sometimes corticosteroid therapy.
Related Concept Videos
Hepatitis
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Inhibitors of Viral Protein Synthesis
Cytomegalovirus Disease
Viral Hepatitis I: Introduction

